Generate a tailored SOP for Dr. Stephen Hanessian. Improve your application with a focused, well-structured draft.
Stephen Hanessian is a global leader in organic chemistry, medicinal chemistry, and bio-organic chemistry. He joined the Department of Chemistry at the Université de Montréal in 1969 and has trained over 300 students and postdoctoral researchers. He held the Isis Pharmaceuticals Research Chair, producing research that has led to the development of new drugs, including antibiotics and antiviral and anti-leukemic agents. His contributions to total synthesis and natural products have been significant, particularly in the field of therapeutic product development and new methods in asymmetric synthesis. Hanessian's research expertise encompasses organic chemistry, medicinal chemistry, and chemical biology, focusing on drug discovery and catalysis. He has published extensively in the field, significantly impacting drug development through his innovative methodologies.
Université de Montréal • Montréal, QC
Conducts research on total synthesis of natural products of biological importance, design and synthesis of therapeutic products, and development of new methods in asymmetric synthesis.
Department of Pharmacology and Physiology - Research intensive with options in Neuropharmacology and Pharmacogenomics.